MedX Health Corp. announced the signing of a commercial distribution agreement with Makromed/Arhan Global A.S following the conclusion of its successful paid pilot project. In conjunction with signing the agreement, Makromed has committed to an initial 60-unit order for 2022, with an immediate order of 40 units and an option for 20 more units to be confirmed by October 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 CAD | 0.00% | +16.67% | +16.67% |
05-31 | MedX Health Corp. Brief: Announced Proposed Extension of Non-brokered Private Placement Offering | MT |
05-30 | MedX Health Corp Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+16.67% | 13.78M | |
+4.57% | 212B | |
+8.61% | 186B | |
+26.34% | 151B | |
+33.90% | 114B | |
+2.17% | 65.57B | |
+14.50% | 52.61B | |
-3.30% | 46.8B | |
-3.98% | 38.95B | |
+6.66% | 37.64B |
- Stock Market
- Equities
- MDX Stock
- News MedX Health Corp
- Medx Health Corp. Signs Commercial Distribution Agreement with Makromed/Arhan Global A.S to Launch Medx's Teledermatology Screening Platform in Turkey